Enanta Pharmaceuticals, Inc. NONSTATUTORY STOCK OPTION GRANT NOTICE AND AGREEMENT (2024 INDUCEMENT STOCK INCENTIVE PLAN)Nonstatutory Stock Option Agreement • November 27th, 2024 • Enanta Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Nonstatutory Stock Option Certificate confirms that Enanta Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, has granted to the person named below (“Participant”) a Nonstatutory Stock Option (this “Option”) to purchase the number of shares of the Company’s Common Stock set forth below pursuant to the Company’s 2024 Inducement Stock Incentive Plan (the “Plan”), subject to adjustment as provided below and subject to the definitions and terms and conditions set forth or otherwise referenced below.
THIRD AMENDMENT TO LEASE AGREEMENTLease Agreement • November 27th, 2024 • Enanta Pharmaceuticals Inc • Pharmaceutical preparations
THIS THIRD AMENDMENT TO LEASE AGREEMENT (this “Third Amendment”) is dated as of September 13, 2024, but made effective as of September 1, 2024, by and between ARE-MA REGION NO. 75, LLC, a Delaware limited liability company (“Landlord”), and ENANTA PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).
SECOND AMENDMENT TO LEASE AGREEMENTLease Agreement • November 27th, 2024 • Enanta Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
THIS SECOND AMENDMENT TO LEASE AGREEMENT (this “Second Amendment”) is made as of July 26, 2024, by and between ARE-MA REGION NO. 75, LLC, a Delaware limited liability company (“Landlord”), and ENANTA PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).
RESTRICTED STOCK UNIT GRANT NOTICE AND AWARD AGREEMENT (2024 Inducement Stock INCENTIVE PLAN)Restricted Stock Unit Grant Agreement • November 27th, 2024 • Enanta Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This notice confirms that Enanta Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, has granted to the person named below (“Participant”) an award (this “Award”) of the number of Restricted Stock Units (the “RSUs”) set forth below pursuant to the Company’s 2024 Inducement Stock Incentive Plan (the “Plan”), each RSU representing the right to receive one share of the Company’s Common Stock, $.01 par value per share (the “Common Stock”), as provided below and subject to the definitions and terms and conditions referenced below.
